For the month of April 2026.
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Exhibit 99.1

AYR Wellness Announces Closing of Exit Facility
and Related Transactions
MIAMI,
April 10, 2026 - AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the
“Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial closing of the transfer
of its Virginia operations into Arboretum Virginia LLC, a wholly-owned subsidiary of Arboretum Bidco LLC (“Arboretum”), and
the closing and initial funding of its new money exit facility (the “Exit Facility”) with Arboretum, in connection with the
Company’s previously announced restructuring transactions (the “Restructuring Transactions”). Arboretum, which intends
to operate under the trade name “Ayr Wellness,” is the entity established by the Company’s senior secured noteholders
as the designated purchaser under the Master Purchase Agreement, dated November 14, 2025 (the “MPA”). Additional state-level
operations to be acquired under the MPA are expected to transfer into Arboretum as requisite regulatory approvals are obtained. This
initial closing marks the occurrence of the first state-specific closing under the MPA.
The Exit Facility consists of
a $275 million senior secured delayed draw term loan facility, backstopped by Millstreet Capital Management LLC, with participation rights
available to other holders of the Company’s senior secured notes on a pro rata basis. The Exit Facility bears interest at a rate
of 13.00% per annum, with a payment-in-kind option for the first 24 months and cash pay thereafter, and matures five years from the initial
funding date. The Exit Facility is secured by a first lien on substantially all of the assets of Arboretum and the applicable guarantors
under the Exit Facility. The Exit Facility includes the take-back debt facility (the “Take-Back Facility”), into which outstanding
obligations under Tranche A of the Company’s existing bridge credit facility (the “Bridge Facility”) are being rolled-over,
on a pari passu basis.
In connection with this initial
closing, a pro rata portion of Tranche A of the Company’s existing $50 million Bridge Facility, together with accrued and capitalized
interest, has been assumed by Arboretum and converted on a dollar-for-dollar basis into the Take-Back Facility. Similarly, each holder
of senior secured notes of AYR has received, in satisfaction and release of its allocable share of the noteholders’ credit bid amount
attributable to the Company’s Virginia operations, its corresponding pro rata share of new equity interests issued in connection
with the Company’s Virginia operations by Arboretum Investments LLC, the ultimate parent entity that, directly or indirectly, owns
100% of the equity interests in Arboretum, subject to dilution by a management incentive plan and certain premiums payable in equity under
the Bridge Facility and the Exit Facility. The remaining portions of Tranche A of the existing Bridge Facility will roll-over into the
Exit Facility on a state-by-state basis as each subsequent closing occurs. Similarly, the remaining AYR senior secured notes will be satisfied
and exchanged for equity interests in Arboretum Investments LLC as future closings occur for operations in states other than Virginia.
The Restructuring Transactions are expected to reduce leverage, improve earnings and cash flow, and strengthen interest coverage for Arboretum.
Concurrently, the Company has
continued to progress its proceedings under the Companies’ Creditors Arrangement Act (Canada) in the Supreme Court of British
Columbia to effectuate a liquidation and wind-down of the Company.
In connection with the Restructuring Transactions, the Company is advised by DLA Piper LLP as legal counsel, Moelis & Company as investment
banker and Ankura Consulting Group as financial advisors. Certain senior secured noteholders and lenders under the Bridge and Exit Facilities
are advised by Paul Hastings LLP as legal counsel, Feuerstein Kulick LLP as regulatory counsel, Goodmans LLP as Canadian legal counsel,
and Ducera Partners LLC as financial advisors.
Forward-Looking Statements
Certain statements contained in this news release
may contain forward-looking information or may be forward-looking statements (collectively, "forward-looking statements") within
the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by the use of words such as
"target", "expect", "anticipate", "believe", "foresee", "could", "would",
"estimate", "goal", "outlook", "intend", "plan", "seek", "will",
"may", "tracking", "pacing" and "should" and similar expressions or words suggesting future outcomes.
This news release includes forward-looking statements pertaining to, among other things, the anticipated use of proceeds from the Exit
Facility, the expected transfer of assets into Arboretum, the anticipated impact of the transactions on the Company’s leverage and
financial performance, the expected timing of regulatory approvals, and the Company’s and/or Arboretum’s future financial
outlook. Numerous risks and uncertainties could cause actual events and results to differ materially from the estimates, beliefs and assumptions
expressed or implied in the forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that
may cause actual results to differ materially from those anticipated. Numerous risks and uncertainties could cause actual events and results
to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Forward-looking
statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those anticipated.
These risks and uncertainties include, among others, those described in the Company’s public filings, market and regulatory factors,
and other risks inherent in the cannabis industry. AYR has no intention, and undertakes no obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events, or otherwise, except as required by law.
About AYR Wellness Inc.
AYR Wellness is a vertically integrated U.S.
multi-state cannabis operator with over 90 licensed retail locations across Florida, Pennsylvania, Massachusetts, New Jersey, Ohio,
Nevada, and Virginia. The Company cultivates, manufactures, and retails a broad portfolio of high-quality cannabis products, supporting
both medical patients and adult-use consumers. AYR also offers a growing suite of CPG brands—including Kynd, Haze, and Later Days—designed
to meet a wide range of consumer needs across its markets.
For more information, please visit www.ayrwellness.com.
Company/Media Contact:
Robert Vanisko
SVP, Public Affairs
T: (786) 885-0397
Email: comms@ayrwellness.com